US Stock MarketDetailed Quotes

TELO Telomir Pharmaceuticals

Watchlist
  • 4.670
  • +0.450+10.66%
Trading Nov 6 14:07 ET
138.28MMarket Cap-7377P/E (TTM)

Telomir Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
3.38%1.47M
296.75%1.92M
361.52%3.94M
121.44%1.08M
308.64%954.15K
1,935.76%1.43M
482.94K
518.36%854.15K
487.1K
233.5K
Selling and administrative expenses
1,363.55%879.7K
1,640.58%741.54K
2,766.11%600.19K
3,937.28%395.29K
2,625.09%102.19K
1,502.85%60.11K
--42.6K
79.92%20.94K
--9.79K
--3.75K
-General and administrative expense
1,363.55%879.7K
1,640.58%741.54K
2,766.11%600.19K
3,937.28%395.29K
2,625.09%102.19K
1,502.85%60.11K
--42.6K
79.92%20.94K
--9.79K
--3.75K
Research and development costs
-10.91%594.8K
82.59%804.02K
88.95%1.57M
-57.31%203.78K
14.28%262.56K
906.76%667.63K
--440.34K
558.70%833.21K
--477.31K
--229.75K
Other operating expenses
----
--370.5K
--1.77M
--479.55K
--589.4K
--698.6K
----
----
----
----
Operating profit
-3.38%-1.47M
-296.75%-1.92M
-361.52%-3.94M
-121.44%-1.08M
-308.64%-954.15K
-1,935.76%-1.43M
-482.94K
-518.36%-854.15K
-487.1K
-233.5K
Net non-operating interest income expense
120.55%25.49K
-4.34M
-1.64M
-761.82K
-757.17K
-124.05K
0
0
0
0
Non-operating interest income
--25.49K
----
----
----
----
--0
----
----
----
----
Non-operating interest expense
--0
--4.34M
--1.64M
--761.82K
--757.17K
--124.05K
--0
--0
--0
--0
Other net income (expense)
-7.49M
Special income (charges)
----
----
---7.49M
----
----
----
----
--0
----
----
-Less:Other special charges
----
----
--7.49M
----
----
----
----
----
----
----
Income before tax
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
-632.91%-1.71M
-2,112.81%-1.55M
-482.94K
-518.36%-854.15K
-487.1K
-233.5K
Income tax
Net income
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
-632.91%-1.71M
-2,112.81%-1.55M
-482.94K
-518.36%-854.15K
-487.1K
-233.5K
Net income continuous Operations
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
-632.91%-1.71M
-2,112.81%-1.55M
---482.94K
-518.36%-854.15K
---487.1K
---233.5K
Minority interest income
Net income attributable to the parent company
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
-632.91%-1.71M
-2,112.81%-1.55M
-482.94K
-518.36%-854.15K
-487.1K
-233.5K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
-632.91%-1.71M
-2,112.81%-1.55M
-482.94K
-518.36%-854.15K
-487.1K
-233.5K
Basic earnings per share
4.51%-0.05
-1,310.18%-0.23
-1,430.39%-0.4415
-1,814.92%-0.315
-632.89%-0.0578
-2,113.06%-0.0524
-0.0163
-518.37%-0.0288
-0.0165
-0.0079
Diluted earnings per share
4.51%-0.05
-1,310.18%-0.23
-1,430.39%-0.4415
-1,814.92%-0.315
-632.89%-0.0578
-2,113.06%-0.0524
-0.0163
-518.37%-0.0288
-0.0165
-0.0079
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 3.38%1.47M296.75%1.92M361.52%3.94M121.44%1.08M308.64%954.15K1,935.76%1.43M482.94K518.36%854.15K487.1K233.5K
Selling and administrative expenses 1,363.55%879.7K1,640.58%741.54K2,766.11%600.19K3,937.28%395.29K2,625.09%102.19K1,502.85%60.11K--42.6K79.92%20.94K--9.79K--3.75K
-General and administrative expense 1,363.55%879.7K1,640.58%741.54K2,766.11%600.19K3,937.28%395.29K2,625.09%102.19K1,502.85%60.11K--42.6K79.92%20.94K--9.79K--3.75K
Research and development costs -10.91%594.8K82.59%804.02K88.95%1.57M-57.31%203.78K14.28%262.56K906.76%667.63K--440.34K558.70%833.21K--477.31K--229.75K
Other operating expenses ------370.5K--1.77M--479.55K--589.4K--698.6K----------------
Operating profit -3.38%-1.47M-296.75%-1.92M-361.52%-3.94M-121.44%-1.08M-308.64%-954.15K-1,935.76%-1.43M-482.94K-518.36%-854.15K-487.1K-233.5K
Net non-operating interest income expense 120.55%25.49K-4.34M-1.64M-761.82K-757.17K-124.05K0000
Non-operating interest income --25.49K------------------0----------------
Non-operating interest expense --0--4.34M--1.64M--761.82K--757.17K--124.05K--0--0--0--0
Other net income (expense) -7.49M
Special income (charges) -----------7.49M------------------0--------
-Less:Other special charges ----------7.49M----------------------------
Income before tax 6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M-632.91%-1.71M-2,112.81%-1.55M-482.94K-518.36%-854.15K-487.1K-233.5K
Income tax
Net income 6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M-632.91%-1.71M-2,112.81%-1.55M-482.94K-518.36%-854.15K-487.1K-233.5K
Net income continuous Operations 6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M-632.91%-1.71M-2,112.81%-1.55M---482.94K-518.36%-854.15K---487.1K---233.5K
Minority interest income
Net income attributable to the parent company 6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M-632.91%-1.71M-2,112.81%-1.55M-482.94K-518.36%-854.15K-487.1K-233.5K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M-632.91%-1.71M-2,112.81%-1.55M-482.94K-518.36%-854.15K-487.1K-233.5K
Basic earnings per share 4.51%-0.05-1,310.18%-0.23-1,430.39%-0.4415-1,814.92%-0.315-632.89%-0.0578-2,113.06%-0.0524-0.0163-518.37%-0.0288-0.0165-0.0079
Diluted earnings per share 4.51%-0.05-1,310.18%-0.23-1,430.39%-0.4415-1,814.92%-0.315-632.89%-0.0578-2,113.06%-0.0524-0.0163-518.37%-0.0288-0.0165-0.0079
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data